Lupin launches Risperidone extended-release injectable suspension in the U.S. with 180-day CGT… EP News Bureau Nov 14, 2025 The launch marks Lupin’s first product using PrecisionSphereTM, the long-acting injectable platform developed by Nanomi B.V.
